HHS Template - SSJ under FAR Part 12.pdf

Sole Source Justification (SSJ) RFO - FAR 12.102(b) & 12.201-1 / 12.201-2 / 12.001(c)

1. Acquisition Title:

ALCOR Scientific Division: Albuquerque Area IHS Contracting Activity: New Contract request Author: Vanessa Vicenti, COR Basis for approval: Individual

2. Nature and/or Description of the Action being Approved:

The Albuquerque Area Laboratory Programs would like to contract with ALCOR for continued lease of iSED Elite and miniiSED analyzers. Leased contract will include testing equipment, consumables/supplies, and maintenance/PM services. Contract request is not for new analyzers or equipment. Contract price must include equipment, consumables, annual services, and freight charges. Contract will be to lease analyzers for one (1) year. Contract will be a firm fixed priced contract.

Contractor: Fisher Scientific Company LLC Performance Period

Dates/Duration Unit Price/CLIN Multiplier Total

5/1/2026 – 4/30/2027

12 months Varies 1 $57,875.00

Estimated Total Dollar Value: $57,875.00 Original Contract Value: $57,875.00 New Contract Value: $57,875.00

3. Description of Supplies and/or Services:

Albuquerque Area Indian Health Service laboratory programs need a contract with ALCOR Scientific to continue support services with consumables and preventative maintenance (PM) services. This contract request is for all Albuquerque Area Indian Health Service laboratories.

4. Statutory Authority Cited and Rationale:

Authority This justification for other than full and open competition is conducted pursuant to 41 U.S.C.

3304(a)(2), as implemented by RFO – FAR 6.103-2, “Unusual and Compelling Urgency.” This acquisition is conducted in accordance with RFO – FAR Part 12 procedures applicable to acquisitions below $9 million.

Rationale for Use of Other Than Full and Open Competition The Government requires the immediate issuance of an emergency contract to ensure continuity of patient care and the uninterrupted delivery of essential laboratory services while a long-term contract, consisting of a base period and four option years, is being developed and awarded.

A delay in contract award would pose a substantial and unacceptable risk to all federal laboratory facilities within the Albuquerque Area, potentially resulting in the discontinuation of in-house laboratory testing for Erythrocyte Sedimentation Rate (ESR). Such disruption would adversely impact clinical operations and compromise the Government’s ability to meet its mission requirements for patient care.

Demonstration of Unique Qualifications / Nature of the Acquisition Due to the urgent and compelling nature of the requirement, and the need to avoid any lapse in critical laboratory services, the Government must proceed with a sole source acquisition. The selected contractor is the only responsible source capable of providing the required services within the necessary timeframe to prevent disruption.

Full and open competition would result in unacceptable delays and is therefore not in the best interest of the Government.

Conclusion Based on the foregoing, the use of other than full and open competition is justified to ensure continuity of critical healthcare services and to prevent adverse impacts to patient care and laboratory operations.

5. Special Considerations for Certain Contract Extensions or Bridge Contracts:

None apply for this contract request.

6. Actions to Increase Competition:

a. A Synopsis Was / Was Not Published: A Synopsis was not published for this contract request.

b. Responses Were / Were Not Received: N/A, a Synopsis was not published for this contract request.

c. Sources Expressing Interest: No sources received at this time who expressed interest.

d. Actions to Foster Competition for Future, Similar Requirements: Future contracts will be solicited.

7. Market Research:

ALCOR equipment is installed and validated for use in all IHS federal laboratories in the Albuquerque Area. It is in the Government’s best interest to continue awarding a sole-source contract to ALCOR for their proprietary equipment and software.

8. Procurement history:

a. Contractor:

Contract or Order Number:75H70725P00124 Award Date and Period of Performance: 5/1/2025-4/30/2026

Value (including all options): $57,455.36 Competitive Status: Not competed

Authority formerly relied upon if Not Competed: FAR 8.405-6(a)(1)(i)(A)

9. Additional Information or Other Facts: N/A

10. Technical or Requirements Program Management Certification: I certify that the supporting data under my cognizance which are included in the justification is accurate and complete to the best of my knowledge and belief.

Vanessa Vicenti Area Laboratory Consultant Signature & Date:

12. Fair and Reasonable Price Determination: As the contracting officer, I hereby determine that the anticipated price to the Government for this contract action will be fair and reasonable, based upon the following: See RFO - FAR 12.204 for further guidance.

Select the applicable squares to mark the techniques used:

☐ (1) Price reasonableness based on competitive quotations or offers.

☐ (2) If only one response is received, include a statement of price reasonableness in the contract file.

The contracting officer may base the statement on— ☐ (i) Market research.

☐ (ii) Comparison of proposed price with prices found reasonable on previous purchases.

☐ (iii) Current price lists, catalogs, or advertisements. However, inclusion of a price in a price list, catalog, or advertisement does not, in and of itself, establish fairness and reasonableness.

☐ (iv) A comparison with similar items in a related industry.

☐ (v) The contracting officer’s personal knowledge of the item being purchased.

☐ (vi) Comparison to an independent Government estimate.

☐ (vii) Any other reasonable basis, as follows: Explain, if applicable.

13. Contracting Officer (CO) Certification and Approval: I hereby certify that this justification is accurate and complete to the best of my knowledge and belief. [Always required; CO approval authority is limited to $900 thousand.]

Contracting Officer Signature & Date:

ELEVATED REVIEWS & APPROVALS

14. Advocate for Competition (AfC) Review and Approval: I reviewed this justification and find that it adequately supports a sole source acquisition. [Division AfC approval authority is limited to $20 million.]

Advocate for Competition Signature & Date:

15. Head of the Contracting Activity (HCA) Review and Approval: I reviewed this justification and find that it adequately supports a sole source acquisition. [HCA approval authority is limited to $90 million.]

Head of the Contracting Activity Signature & Date:

16. HHS Office of General Counsel Review and Concurrence: I reviewed this justification and concur that it adequately supports a sole source acquisition. [Mandatory when SPE approval is required, unless otherwise waived in writing by the SPE.]

General Counsel Review Signature & Date:

17. HHS Advocate for Competition (AfC) Review and Concurrence: I reviewed this justification and concur that it adequately supports a sole source acquisition

HHS Advocate for Competition Signature & Date:

FINAL APPROVAL

18. HHS Senior Procurement Executive Approval: Based on the foregoing, I hereby approve this sole source justification pursuant to the authority cited in section 4 above. [Required if the total award value, including all options and FAR 52.217-8 value, exceeds $90 million.]

HHS Senior Procurement Executive Signature & Date: